<?xml version="1.0" encoding="utf-8"?> <feed xmlns:dc="http://dublincore.org/documents/dcmi-namespace/" xmlns:media="http://search.yahoo.com/mrss/" xmlns="http://www.w3.org/2005/Atom"> <title type="text">The Weinbach Group, Inc.</title> <subtitle type="text">Contains the last 20 releases</subtitle> <id>uuid:bf6913df-cc6d-4f7b-bcd1-bc2d30c74e6c;id=16068</id> <rights type="text">Copyright 2017, The Weinbach Group, Inc.</rights> <updated>2017-04-25T14:00:00Z</updated> <author> <name>newsdesk@globenewswire.com (NewsDesk)</name> <uri>http://www.globenewswire.com/LegacyRss?Length=4</uri> <email>newsdesk@globenewswire.com</email> </author> <link rel="alternate" href="https://www.globenewswire.com/atomfeed/organization/ZBg8EbZ1ECSprGAG8nXoWg==" /> <link rel="self" href="https://www.globenewswire.com/atomfeed/organization/ZBg8EbZ1ECSprGAG8nXoWg==" /> <entry> <id>https://www.globenewswire.com/news-release/2017/04/25/971052/0/en/Black-Owned-Media-Alliance-Nominates-Miami-Firm-for-Advertising-Agency-of-the-Year.html</id> <title type="text">Black Owned Media Alliance Nominates Miami Firm for “Advertising Agency of the Year”</title> <published>2017-04-25T14:00:00Z</published> <updated>2024-11-23T17:31:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/04/25/971052/0/en/Black-Owned-Media-Alliance-Nominates-Miami-Firm-for-Advertising-Agency-of-the-Year.html" /> <content type="html"><![CDATA[The Weinbach Group Earns Recognition For Its Positive Impact In The Black Community <pre>The Weinbach Group Earns Recognition For Its Positive Impact In The Black Community</pre>]]></content> <dc:identifier>971052</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>The Weinbach Group, Inc.</dc:contributor> <dc:modified>Tue, 25 Apr 2017 14:00 GMT</dc:modified> <dc:subject>Company Announcement</dc:subject> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/02/10/965076/0/en/Be-Strong-International-Hires-Miami-Public-Relations-Firm-to-Expand-Reach.html</id> <title type="text">Be Strong International Hires Miami Public Relations Firm to Expand Reach </title> <published>2017-02-10T19:00:00Z</published> <updated>2024-11-23T17:31:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/02/10/965076/0/en/Be-Strong-International-Hires-Miami-Public-Relations-Firm-to-Expand-Reach.html" /> <content type="html"><![CDATA[<p><em><p>The Weinbach Group Will Focus On Branding And Increasing Visibility For Non-Profit Serving Teens And Young Adults</p></em></p><p>MIAMI, FL--(Marketwired - Feb 10, 2017) - The Weinbach Group, a leading <a rel="nofollow" href="http://www.weinbachgroup.com/miami-ad-agency/" title="Miami ad agency">Miami ad agency</a> with recognized expertise in the non-profit sector, announced today that it was selected by Be Strong International to serve as the organization's <a rel="nofollow" href="http://www.weinbachgroup.com/marketing-communications-firm/" title="marketing communications firm">marketing communications firm</a>. The Weinbach Group will refine Be Strong's branding, develop communications materials, and expand its reach to public schools and churches, where it delivers educational workshops focused on building healthy relationships. Be Strong won a capacity-building grant from The Children's Trust, and a portion of the proceeds will finance its marketing program and help dramatically expand the non-profit's impact.</p>]]></content> <dc:identifier>965076</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>The Weinbach Group</dc:contributor> <dc:modified>Thu, 14 Sep 2017 02:40 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/01/11/965075/0/en/HCA-Selects-Healthcare-Marketing-Firm-to-Promote-Its-Greater-Houston-Physician-Group-of-More-Than-150-Providers.html</id> <title type="text">HCA Selects Healthcare Marketing Firm to Promote Its Greater Houston Physician Group of More Than 150 Providers </title> <published>2017-01-11T16:00:00Z</published> <updated>2024-11-23T17:31:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/01/11/965075/0/en/HCA-Selects-Healthcare-Marketing-Firm-to-Promote-Its-Greater-Houston-Physician-Group-of-More-Than-150-Providers.html" /> <content type="html"><![CDATA[<p><em><p>The Weinbach Group Will Use Digital and Conventional Approaches to Grow Patient Volumes</p></em></p><p>MIAMI, FL--(Marketwired - Jan 11, 2017) - The Weinbach Group, a leading <a rel="nofollow" href="http://www.weinbachgroup.com/marketing-communications-firm/" title="marketing communications firm">marketing communications firm</a> with a long track record of success in the healthcare sector, added HCA Gulf Coast Physician Services Group to its client roster. The Weinbach Group will help the multi-specialty practice comprised of nearly 150 physicians and more than 500 support personnel to streamline its brand, launch internal communications, and implement patient volume growth campaigns.</p>]]></content> <dc:identifier>965075</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>The Weinbach Group</dc:contributor> <dc:modified>Thu, 14 Sep 2017 02:40 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2016/06/07/965074/0/en/Miami-Based-Healthcare-Marketing-Firm-Dominates-in-National-Advertising-Competition.html</id> <title type="text">Miami-Based Healthcare Marketing Firm Dominates in National Advertising Competition </title> <published>2016-06-07T15:30:00Z</published> <updated>2024-11-23T17:31:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2016/06/07/965074/0/en/Miami-Based-Healthcare-Marketing-Firm-Dominates-in-National-Advertising-Competition.html" /> <content type="html"><![CDATA[<p><em><p>The Weinbach Group's Advertising for Jackson Wins More Awards Than Any Hospital or Health System in Florida</p></em></p><p>MIAMI, FL--(Marketwired - Jun 7, 2016) - The Weinbach Group, a leading <a rel="nofollow" href="http://www.weinbachgroup.com/miami-public-relations-firm/" title="Miami public relations firm">Miami public relations firm</a> and <a rel="nofollow" href="http://www.weinbachgroup.com/healthcare-advertising-agency/" title="healthcare advertising agency">healthcare advertising agency</a>, announced it racked up sixteen wins in the 33rd Annual Healthcare Advertising Awards, one of the nation's oldest and most-respected healthcare marketing contests. The Weinbach Group serves as agency of record for Jackson Health System, the largest public hospital system in the U.S., and its out-of-the-ordinary work for Jackson won more awards than any hospital in Florida. In addition, the <a rel="nofollow" href="http://www.weinbachgroup.com/healthcare-marketing-firm/" title="healthcare marketing firm">healthcare marketing firm</a> won recognition for projects it created for other industry clients, including TopLine MD.</p>]]></content> <dc:identifier>965074</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>The Weinbach Group</dc:contributor> <dc:modified>Thu, 14 Sep 2017 02:40 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2016/05/26/965073/0/en/Miami-Advertising-and-P-R-Firm-Promotes-From-Within.html</id> <title type="text">Miami Advertising and P.R. Firm Promotes From Within </title> <published>2016-05-26T15:59:21Z</published> <updated>2024-11-23T17:31:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2016/05/26/965073/0/en/Miami-Advertising-and-P-R-Firm-Promotes-From-Within.html" /> <content type="html"><![CDATA[<p><em><p>The Weinbach Group Names Meieli Sawyer Director of Communications</p></em></p><p>MIAMI, FL--(Marketwired - May 26, 2016) - The Weinbach Group, a leading <a rel="nofollow" href="http://www.weinbachgroup.com/miami-public-relations-firm/" title="Miami public relations firm">Miami public relations firm</a> and advertising agency, announced the promotion of Meieli Sawyer to director of communications. In her new role, Ms. Sawyer will coordinate strategic and tactical public relations, develop advertising campaigns, and oversee the agency's copywriting department. She will also collaborate with the agency's account services team to ensure marketing, communications, and public relations remain consistent with clients' positioning and overarching goals. She previously served as a communications specialist at the firm and will continue to contribute to copywriting and public relations, with an increased focus on client strategy. </p>]]></content> <dc:identifier>965073</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>The Weinbach Group</dc:contributor> <dc:modified>Thu, 14 Sep 2017 02:40 GMT</dc:modified> <media:content medium="image" type="image/jpeg" width="600" url="http://media.marketwire.com/attachments/201605/41521_Meieli_Sawyer.jpg"> <media:text type="html"><![CDATA[<p> <a href="https://www.globenewswire.com/news-release/2016/05/26/965073/0/en/Miami-Advertising-and-P-R-Firm-Promotes-From-Within.html"> <img src="http://media.marketwire.com/attachments/201605/41521_Meieli_Sawyer.jpg" width="600" align="left" border="0" alt="Photo" title="Meieli Sawyer" /> </a> </p><br clear="all" />]]></media:text> <media:credit role="publishing company">GlobeNewswire Inc.</media:credit> </media:content> </entry> <entry> <id>https://www.globenewswire.com/news-release/2016/03/30/965072/0/en/The-Weinbach-Group-Hires-Jason-Lopez-as-Communications-Specialist.html</id> <title type="text">The Weinbach Group Hires Jason Lopez as Communications Specialist </title> <published>2016-03-30T18:00:00Z</published> <updated>2024-11-23T17:31:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2016/03/30/965072/0/en/The-Weinbach-Group-Hires-Jason-Lopez-as-Communications-Specialist.html" /> <content type="html"><![CDATA[<p><em><p>Miami P.R. Firm Expanding Social Media Services</p></em></p><p>MIAMI, FL--(Marketwired - Mar 30, 2016) - The Weinbach Group, a leading <a rel="nofollow" href="http://www.weinbachgroup.com/miami-public-relations-firm/" title="Miami public relations firm">Miami public relations firm</a> and advertising agency announced the addition of Jason Lopez to its professional staff, where he will serve as communications specialist. In his new position, Jason will be responsible for much of the content development required by the firm's clients. He will also handle public relations and publicity activities, as well as spearhead the firm's growing social media services. He brings nearly a decade of journalism experience, including knowledge earned at previous posts in television and radio news.</p>]]></content> <dc:identifier>965072</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>The Weinbach Group</dc:contributor> <dc:modified>Thu, 14 Sep 2017 02:40 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2016/02/29/965071/0/en/Brandix-i3-Expands-Healthcare-Expertise-With-the-Announcement-of-Two-Executives.html</id> <title type="text">Brandix i3 Expands Healthcare Expertise With the Announcement of Two Executives </title> <published>2016-02-29T19:00:00Z</published> <updated>2024-11-23T17:31:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2016/02/29/965071/0/en/Brandix-i3-Expands-Healthcare-Expertise-With-the-Announcement-of-Two-Executives.html" /> <content type="html"><![CDATA[<p>ROCHESTER, MN--(Marketwired - Feb 29, 2016) - Brandix i3, a fast growing technology company that develops and implements industry-leading healthcare software, including <a rel="nofollow" href="http://healthcare.brandixi3.com/patient-safety-software/" title="patient safety software">patient safety software</a> and healthcare <a rel="nofollow" href="http://healthcare.brandixi3.com/solutions/infor-bi/" title="business intelligence solutions">business intelligence solutions</a> announced the appointment of two senior-level executives to its U.S. team: <strong>John L. Hamm</strong>; Vice President of Sales, and <strong>Thomas (Tom) Bithell</strong>; U.S. Sales Manager. This addition will better enable the development and delivery of innovative applications, expansion of market opportunities and client relationships, and building of new business partnerships designed to support the critical needs of today's healthcare environment. </p>]]></content> <dc:identifier>965071</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Brandix i3</dc:contributor> <dc:modified>Thu, 14 Sep 2017 02:40 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2016/01/28/965070/0/en/Rennova-Health-Inc-Granted-U-S-Trademark-for-StableSpot-R-a-Laboratory-Specimen-Transport-System.html</id> <title type="text">Rennova Health, Inc. Granted U.S. Trademark for StableSpot(R), a Laboratory Specimen Transport System </title> <published>2016-01-28T22:00:00Z</published> <updated>2024-11-23T17:31:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2016/01/28/965070/0/en/Rennova-Health-Inc-Granted-U-S-Trademark-for-StableSpot-R-a-Laboratory-Specimen-Transport-System.html" /> <content type="html"><![CDATA[<p><em><p>New System Will Lead to Drastic Reduction in Laboratory Supply Costs</p></em></p><p>WEST PALM BEACH, FL--(Marketwired - Jan 28, 2016) - <strong> </strong>Rennova Health, Inc. (<exchange name="NASDAQ">NASDAQ</exchange>: <ticker name="RNVA">RNVA</ticker>) (<exchange name="NASDAQ">NASDAQ</exchange>: <ticker name="RNVAW">RNVAW</ticker>), which owns and operates a diverse family of healthcare companies, received a trademark from the United States Patent and Trademark Office for StableSpot<sup>®</sup>, a clinical dry specimen transport kit for collection, stabilization, and transport of urine, serum, plasma, and blood. This innovative new approach will provide convenient sample collection for a patient, help protect the integrity of samples, cut down on packing and shipping concerns, and reduce total laboratory supply costs.</p>]]></content> <dc:identifier>965070</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Rennova Health, Inc. </dc:contributor> <dc:modified>Thu, 14 Sep 2017 02:40 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2016/01/27/965069/0/en/Rennova-Health-to-Present-at-Source-Capital-Group-s-2016-Disruptive-Growth-Healthcare-Conference-on-February-11.html</id> <title type="text">Rennova Health to Present at Source Capital Group's 2016 "Disruptive Growth & Healthcare" Conference on February 11 </title> <published>2016-01-27T22:00:00Z</published> <updated>2024-11-23T17:31:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2016/01/27/965069/0/en/Rennova-Health-to-Present-at-Source-Capital-Group-s-2016-Disruptive-Growth-Healthcare-Conference-on-February-11.html" /> <content type="html"><![CDATA[<p><em><p>Presentation Begins at 9 a.m. Eastern Time and Will Be Available via Live Webcast</p></em></p><p>WEST PALM BEACH, FL--(Marketwired - Jan 27, 2016) - Rennova Health, Inc. (<exchange name="NASDAQ">NASDAQ</exchange>: <ticker name="RNVA">RNVA</ticker>) (<exchange name="NASDAQ">NASDAQ</exchange>: <ticker name="RNVAW">RNVAW</ticker>) announced today that CEO Seamus Lagan will provide a company overview at Source Capital Group's 2016 <em>Disruptive Growth & Healthcare Conference</em> on February 11, 2016 in New York City at 9 a.m. Eastern Time.</p>]]></content> <dc:identifier>965069</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Rennova Health, Inc. </dc:contributor> <dc:modified>Thu, 14 Sep 2017 02:40 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2016/01/26/965068/0/en/Georgia-s-Largest-Public-Health-Agency-Signs-Deal-With-Clinlab-for-New-Lab-Information-System.html</id> <title type="text">Georgia's Largest Public Health Agency Signs Deal With Clinlab for New Lab Information System </title> <published>2016-01-26T22:00:00Z</published> <updated>2024-11-23T17:31:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2016/01/26/965068/0/en/Georgia-s-Largest-Public-Health-Agency-Signs-Deal-With-Clinlab-for-New-Lab-Information-System.html" /> <content type="html"><![CDATA[<p><em><p>Contract Is Largest for Clinlab Since It Was Acquired by Rennova Health</p></em></p><p>WEST PALM BEACH, FL--(Marketwired - Jan 26, 2016) - Clinlab, Inc., a subsidiary of Rennova Health, Inc. (<exchange name="NASDAQ">NASDAQ</exchange>: <ticker name="RNVA">RNVA</ticker>) (<exchange name="NASDAQ">NASDAQ</exchange>: <ticker name="RNVAW">RNVAW</ticker>) that develops and markets laboratory information and automation systems, announced today it has entered into an agreement with the Fulton County Department of Health & Wellness to provide technology for faster, more efficient processing and reporting of lab tests.</p>]]></content> <dc:identifier>965068</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Rennova Health, Inc. </dc:contributor> <dc:modified>Thu, 14 Sep 2017 02:40 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2016/01/11/965067/0/en/Novel-Dictation-Based-Electronic-Health-Record-Is-First-of-Its-Kind-to-Be-Certified-by-Federal-Agency.html</id> <title type="text">Novel, Dictation-Based Electronic Health Record Is First of Its Kind to Be Certified by Federal Agency </title> <published>2016-01-11T20:30:00Z</published> <updated>2024-11-23T17:31:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2016/01/11/965067/0/en/Novel-Dictation-Based-Electronic-Health-Record-Is-First-of-Its-Kind-to-Be-Certified-by-Federal-Agency.html" /> <content type="html"><![CDATA[<p><em><p>Medical Mime's M2PRO Meets Standards for "Meaningful Use"; Providers Who Use the Program May Qualify for Financial Incentives</p></em></p><p>WEST PALM BEACH, FL--(Marketwired - Jan 11, 2016) - Medical Mime, an electronic health records company owned by Rennova Health, Inc. (<exchange name="NASDAQ">NASDAQ</exchange>: <ticker name="RNVA">RNVA</ticker>) (<exchange name="NASDAQ">NASDAQ</exchange>: <ticker name="RNVAW">RNVAW</ticker>), announced today that its M2PRO product earned "Meaningful Use" Stage 2 certification as a "Complete Ambulatory EHR" from the Office of the National Coordinator for Health Information Technology (ONC). The designation means Medical Mime's program conforms to the standards and certification criteria adopted by the Secretary of Health and Human Services (HHS). The designation also means that Medical Mime's EHR is included on the Certified Health IT Product List (CHPL), known as "Chapel."</p>]]></content> <dc:identifier>965067</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Rennova Health</dc:contributor> <dc:modified>Thu, 14 Sep 2017 02:40 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2016/01/07/965066/0/en/Rennova-Health-Inc-Issues-Letter-to-Stockholders-Provides-Business-Update-and-Milestones-for-2016.html</id> <title type="text">Rennova Health, Inc. Issues Letter to Stockholders; Provides Business Update and Milestones for 2016 </title> <published>2016-01-07T22:10:00Z</published> <updated>2024-11-23T17:31:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2016/01/07/965066/0/en/Rennova-Health-Inc-Issues-Letter-to-Stockholders-Provides-Business-Update-and-Milestones-for-2016.html" /> <content type="html"><![CDATA[<p>WEST PALM BEACH, FL--(Marketwired - Jan 7, 2016) - <strong>Rennova Health, Inc.</strong> (<exchange name="NASDAQ">NASDAQ</exchange>: <ticker name="RNVA">RNVA</ticker>) (<exchange name="NASDAQ">NASDAQ</exchange>: <ticker name="RNVAW">RNVAW</ticker>) today announced that it has issued a letter to its stockholders providing a business update and milestones for 2016. The text of the letter, which has been posted to the company's website, follows below.</p>]]></content> <dc:identifier>965066</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Rennova Health, Inc.</dc:contributor> <dc:modified>Thu, 14 Sep 2017 02:40 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2015/12/30/965065/0/en/Rennova-Health-Inc-Announces-Closing-of-Public-Offering-of-Securities.html</id> <title type="text">Rennova Health, Inc. Announces Closing of Public Offering of Securities </title> <published>2015-12-30T22:46:32Z</published> <updated>2024-11-23T17:31:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2015/12/30/965065/0/en/Rennova-Health-Inc-Announces-Closing-of-Public-Offering-of-Securities.html" /> <content type="html"><![CDATA[<p>WEST PALM BEACH, FL--(Marketwired - Dec 30, 2015) -  Rennova Health, Inc. (<exchange name="NASDAQ">NASDAQ</exchange>: <ticker name="RNVA">RNVA</ticker>) (<exchange name="NASDAQ">NASDAQ</exchange>: <ticker name="RNVAW">RNVAW</ticker>) ("Company") today announced the closing of an underwritten public offering with total gross proceeds of approximately $10,000,000 before deducting underwriting discounts and commissions, and other offering expenses payable by the Company. The securities offered by the Company consist of Class A Units, with each Class A Unit consisting of one share of the Company's common stock and one immediately exercisable five-year warrant to purchase one share of common stock with a warrant exercise price of $1.9375, and Class B Units, with each Class B Unit consisting of one share of the Company's Series C Convertible Preferred Stock with a stated value of $1,000 and convertible into shares of the Company's common stock at $1.55 per share and immediately exercisable five-year warrants to purchase 645.1613 shares of common stock, with a warrant exercise price of $1.9375. The Class A Units were priced at $1.55. The Class B Units were priced at $1,000. The underwriters have been granted a 45-day option to purchase up to an aggregate of an additional 15% of the securities sold in the offering to cover over-allotments, if any. Rennova Health's common stock and warrants are listed on the NASDAQ Capital Market under the symbol "RNVA" and "RNVAW," respectively. </p>]]></content> <dc:identifier>965065</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Rennova Health, Inc.</dc:contributor> <dc:modified>Thu, 14 Sep 2017 02:40 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2015/12/09/965064/0/en/Minnesota-Based-Health-Technology-Companies-Join-Forces-To-Help-Hospitals-Address-CMS-Sepsis-Guidelines.html</id> <title type="text">Minnesota-Based Health Technology Companies Join Forces To Help Hospitals Address CMS' Sepsis Guidelines </title> <published>2015-12-09T19:00:00Z</published> <updated>2024-11-23T17:31:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2015/12/09/965064/0/en/Minnesota-Based-Health-Technology-Companies-Join-Forces-To-Help-Hospitals-Address-CMS-Sepsis-Guidelines.html" /> <content type="html"><![CDATA[<p><em><p>Brandix i3 And Ambient Clinical Analytics To Jointly Market Sepsis Detection System</p></em></p><p>ROCHESTER, MN--(Marketwired - Dec 9, 2015) - Brandix i3, a healthcare technology company, announced today it has entered into a strategic partnership with Ambient Clinical Analytics Inc. to market and handle site implementation of Ambient Clinical's new, sepsis decision-support system. The <em>Sepsis Detection And Response Tool</em>, marketed under the product name Sepsis DART<sup>®</sup>, allows clinical care organizations to define specific biological metrics that indicate a patient may have or may be developing sepsis. It also provides decision support rules for treating the possible onset of sepsis.</p>]]></content> <dc:identifier>965064</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Brandix i3</dc:contributor> <dc:modified>Thu, 14 Sep 2017 02:40 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2015/11/03/965063/0/en/Rennova-Health-Inc-Announces-Board-of-Directors.html</id> <title type="text">Rennova Health, Inc. Announces Board of Directors </title> <published>2015-11-03T22:35:51Z</published> <updated>2024-11-23T17:31:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2015/11/03/965063/0/en/Rennova-Health-Inc-Announces-Board-of-Directors.html" /> <content type="html"><![CDATA[<p><em><p>New Board Follows Merger Between Medytox Solutions, Inc. and CollabRx, Inc.</p></em></p><p>WEST PALM BEACH, FL--(Marketwired - Nov 3, 2015) - Rennova Health, Inc. (<exchange name="NASDAQ">NASDAQ</exchange>: <ticker name="RNVA">RNVA</ticker>) announces its board of directors boasting years of experience in executive leadership, healthcare, public policy, and financial services. Following the merger between Medytox Solutions, Inc. and CollabRx, Inc. on November 2, 2015, Rennova Health, Inc.'s board includes the following seven members: <strong>Thomas R. Mika, MBA, </strong>as executive chairman of the board; <strong>Paul R. Billings, MD, PhD, FACP, FACMG</strong>, as director; <strong>Michael L. Goldberg</strong>, managing director of Monarch Capital, LLC, as director; <strong>Robert Lee</strong>, managing partner of Sheffield Investment Partners, as director; <strong>Christopher E. Diamantis</strong>, chairman and CEO of Integrated Financial Settlements, Inc.; as director; <strong>Benjamin Frank</strong>, a retired lawyer and businessman with experience in healthcare, foreign trade, retail, business development, and government, as director; and <strong>Seamus Lagan</strong>, CEO of Rennova Health, Inc., as director. </p>]]></content> <dc:identifier>965063</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Rennova Health, Inc.</dc:contributor> <dc:modified>Thu, 14 Sep 2017 02:40 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2015/10/30/965062/0/en/Shareholders-of-Medytox-Solutions-Inc-MMMS-and-CollabRX-Inc-CLRX-Approve-Merger.html</id> <title type="text">Shareholders of Medytox Solutions, Inc. (MMMS) and CollabRX, Inc. (CLRX) Approve Merger </title> <published>2015-10-30T22:19:26Z</published> <updated>2024-11-23T17:31:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2015/10/30/965062/0/en/Shareholders-of-Medytox-Solutions-Inc-MMMS-and-CollabRX-Inc-CLRX-Approve-Merger.html" /> <content type="html"><![CDATA[<p><em><p>Newly Combined Company Expected to Trade on November 3, 2015 as Rennova Health, Inc. (RNVA)</p></em></p><p>WEST PALM BEACH, FL--(Marketwired - Oct 30, 2015) - Medytox Solutions, Inc. ("Medytox") (<exchange name="OTCQB">OTCQB</exchange>: <ticker name="MMMS">MMMS</ticker>), which owns and operates a diverse family of healthcare companies, including five clinical laboratories throughout the U.S., announced today that the shareholders of Medytox and CollabRx, Inc. have approved the proposed merger between Medytox and CollabRx. </p>]]></content> <dc:identifier>965062</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Medytox Solutions, Inc.</dc:contributor> <dc:modified>Thu, 14 Sep 2017 02:40 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2015/10/28/965061/0/en/Medytox-Solutions-Inc-Stockholders-Approve-Merger-With-CollabRx-Inc.html</id> <title type="text">Medytox Solutions, Inc. Stockholders Approve Merger With CollabRx, Inc. </title> <published>2015-10-28T21:37:18Z</published> <updated>2024-11-23T17:31:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2015/10/28/965061/0/en/Medytox-Solutions-Inc-Stockholders-Approve-Merger-With-CollabRx-Inc.html" /> <content type="html"><![CDATA[<p>WEST PALM BEACH, FL--(Marketwired - Oct 28, 2015) - Medytox Solutions, Inc. (<exchange name="OTCQB">OTCQB</exchange>: <ticker name="MMMS">MMMS</ticker>) ("Medytox") announced today it held its Special Meeting of Stockholders to approve the following proposals: (i) to approve and adopt the Agreement and Plan of Merger, dated as of April 15, 2015, by and among CollabRx, Inc., CollabRx Merger Sub, Inc., a direct wholly owned subsidiary of CollabRx formed for the purpose of the merger, and Medytox (the "Merger Agreement"), pursuant to which Medytox will become a wholly owned subsidiary of CollabRx (the "Merger"), and the transactions contemplated by such agreement (the "Merger Proposal") and (ii) to approve any motion to adjourn the Special Meeting, or any adjournment thereof, to another time or place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve and adopt the Merger Agreement and the transactions contemplated thereby (the "Adjournment Proposal"). </p>]]></content> <dc:identifier>965061</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Medytox Solutions, Inc.</dc:contributor> <dc:modified>Thu, 14 Sep 2017 02:40 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2015/09/24/965060/0/en/Medytox-Announces-Special-Meeting-of-Its-Stockholders-to-Be-Held-October-28-2015.html</id> <title type="text">Medytox Announces Special Meeting of Its Stockholders to Be Held October 28, 2015 </title> <published>2015-09-24T16:30:00Z</published> <updated>2024-11-23T17:31:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2015/09/24/965060/0/en/Medytox-Announces-Special-Meeting-of-Its-Stockholders-to-Be-Held-October-28-2015.html" /> <content type="html"><![CDATA[<p>WEST PALM BEACH, FL--(Marketwired - Sep 24, 2015) - <strong> </strong>Medytox Solutions, Inc. (MMMS) ("Medytox") today announced that the registration statement on Form S-4 filed by CollabRx, Inc. (CLRX) ("CollabRx"), and the definitive joint proxy statement/prospectus contained therein, regarding Medytox's proposed merger with CollabRx, has been declared effective by the Securities and Exchange Commission (the "SEC").</p>]]></content> <dc:identifier>965060</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Medytox Solutions, Inc.</dc:contributor> <dc:modified>Thu, 14 Sep 2017 02:40 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2015/09/18/965058/0/en/Medytox-Solutions-Inc-Partners-With-Moments-of-Change-as-Event-Sponsor.html</id> <title type="text">Medytox Solutions, Inc. Partners With "Moments of Change" as Event Sponsor </title> <published>2015-09-18T15:00:00Z</published> <updated>2024-11-23T17:31:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2015/09/18/965058/0/en/Medytox-Solutions-Inc-Partners-With-Moments-of-Change-as-Event-Sponsor.html" /> <content type="html"><![CDATA[<p><em><p>Medytox to Exhibit at Behavioral Health Conference on September 28, 2015</p></em></p><p>WEST PALM BEACH, FL--(Marketwired - Sep 18, 2015) - Medytox Solutions, Inc. (<exchange name="OTCQB">OTCQB</exchange>: <ticker name="MMMS">MMMS</ticker>) announces its partnership with "Moments of Change," an <em>Innovations in Integrated Treatment</em> conference by Foundations Events, which highlights developments in behavioral health for professionals and their patients. The holding company has signed on as an event partner and will highlight its new and innovative approaches to treatment and lab analysis. </p>]]></content> <dc:identifier>965058</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Medytox Solutions, Inc.</dc:contributor> <dc:modified>Thu, 14 Sep 2017 02:40 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2015/09/17/965059/0/en/Medytox-Solutions-Inc-Names-Jason-P-Adams-as-New-Chief-Financial-Officer.html</id> <title type="text">Medytox Solutions, Inc., Names Jason P. Adams as New Chief Financial Officer </title> <published>2015-09-17T21:53:35Z</published> <updated>2024-11-23T17:31:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2015/09/17/965059/0/en/Medytox-Solutions-Inc-Names-Jason-P-Adams-as-New-Chief-Financial-Officer.html" /> <content type="html"><![CDATA[<p><em><p>Multi-Industry Financial Leader Brings Budgeting, Forecasting, and Accounting Expertise to Company</p></em></p><p>WEST PALM BEACH, FL--(Marketwired - Sep 17, 2015) - Medytox Solutions, Inc. (<exchange name="OTCQB">OTCQB</exchange>: <ticker name="MMMS">MMMS</ticker>) announces the appointment of Jason P. Adams to the position of Chief Financial Officer. Mr. Adams will lead Medytox's finance department in integrating financial and operating systems, expanding business partnerships, and improving profitability. </p>]]></content> <dc:identifier>965059</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Medytox Solutions, Inc.</dc:contributor> <dc:modified>Thu, 14 Sep 2017 02:40 GMT</dc:modified> </entry> </feed>